Pearl River Capital’s West Pharmaceutical WST Stock Holding History

Pearl River Capital’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-5,603	Closed	-$1.97M	–	683
2023 Q4	$1.97M	Buy	5,603 +2,485	+80%	+$879K	0.32%	87
2023 Q3	$1.17M	Buy	3,118 +120	+4%	+$46.4K	0.18%	188
2023 Q2	$1.15M	Sell	2,998 -848	-22%	-$303K	0.18%	174
2023 Q1	$1.33M	Buy	+3,846	New	+$1.12M	0.21%	145
2022 Q4	–	Sell	-1,383	Closed	-$340K	–	587
2022 Q3	$340K	Buy	+1,383	New	+$421K	0.06%	355
2020 Q4	–	Sell	-950	Closed	-$261K	–	519
2020 Q3	$261K	Buy	+950	New	+$251K	0.11%	290
2020 Q2	–	Sell	-241	Closed	-$37K	–	597
2020 Q1	$37K	Buy	+241	New	+$37.1K	0.07%	273

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Pearl River Capital's WST Position: Q1 2024 in Review

Pearl River Capital sold out of West Pharmaceutical (WST) in Q1 2024, closing a stake of 5,603 shares — an estimated $1.97M sold.

Pearl River Capital first reported a position in WST in Q1 2020 and held it in 7 quarters. The position peaked at $1.97M in Q4 2023. 778 funds tracked by Wall St. Rank hold WST as of Q1 2024.

Pearl River Capital reported no remaining West Pharmaceutical position as of Q1 2024 after selling out during the quarter.
Pearl River Capital sold 5,603 West Pharmaceutical shares in Q1 2024, an estimated $1.97M.
Pearl River Capital first reported a position in West Pharmaceutical in Q1 2020 and held it in 7 quarters.
Pearl River Capital's West Pharmaceutical position peaked at $1.97M in Q4 2023.
778 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2024.

Based on Pearl River Capital's 13F filing for Q1 2024, filed 14 May 2024.